China Nuclear Medicine/Radiopharmaceutic Market Report & Forecast 2021-2027

Publisher Name :
Date: 26-Oct-2021
No. of pages: 93
Inquire Before Buying

China Nuclear Medicine/Radiopharmaceutic Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Kiloton)

China Nuclear Medicine/Radiopharmaceutic Market Segment Percentages, By Type, 2020 (%)

- Tc-99

- I-123/131

- In-111

- Xe-133

- Th-201

- Ga-67

- Other

China Nuclear Medicine/Radiopharmaceutic Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Kiloton)

China Nuclear Medicine/Radiopharmaceutic Market Segment Percentages, By Application, 2020 (%)

- Diagnostic

- Therapeutic

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Nuclear Medicine/Radiopharmaceutic revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Nuclear Medicine/Radiopharmaceutic revenues share in China market, 2020 (%)

Key companies Nuclear Medicine/Radiopharmaceutic sales in China market, 2016-2021 (Estimated), (Kiloton)

Key companies Nuclear Medicine/Radiopharmaceutic sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- GE Healthcare

- Bracco Imaging

- Mallinckrodt

- Lantheus Medical Imaging

- Bayer

- Jubilant Pharma

- Nordion

- Eli Lilly

- SIEMENS

- China Isotope & Radiation

- Yantai Dongcheng Biochemicals

China Nuclear Medicine/Radiopharmaceutic Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Nuclear Medicine/Radiopharmaceutic Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Nuclear Medicine/Radiopharmaceutic Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Nuclear Medicine/Radiopharmaceutic Overall Market Size
2.1 China Nuclear Medicine/Radiopharmaceutic Market Size: 2021 VS 2027
2.2 China Nuclear Medicine/Radiopharmaceutic Revenue, Prospects & Forecasts: 2016-2027
2.3 China Nuclear Medicine/Radiopharmaceutic Sales: 2016-2027
3 Company Landscape
3.1 Top Nuclear Medicine/Radiopharmaceutic Players in China Market
3.2 Top China Nuclear Medicine/Radiopharmaceutic Companies Ranked by Revenue
3.3 China Nuclear Medicine/Radiopharmaceutic Revenue by Companies
3.4 China Nuclear Medicine/Radiopharmaceutic Sales by Companies
3.5 China Nuclear Medicine/Radiopharmaceutic Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Nuclear Medicine/Radiopharmaceutic Companies in China Market, by Revenue in 2020
3.7 Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nuclear Medicine/Radiopharmaceutic Players in China Market
3.8.1 List of Tier 1 Nuclear Medicine/Radiopharmaceutic Companies in China
3.8.2 List of Tier 2 and Tier 3 Nuclear Medicine/Radiopharmaceutic Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Nuclear Medicine/Radiopharmaceutic Market Size Markets, 2021 & 2027
4.1.2 Tc-99
4.1.3 I-123/131
4.1.4 In-111
4.1.5 Xe-133
4.1.6 Th-201
4.1.7 Ga-67
4.1.8 Other
4.2 By Type - China Nuclear Medicine/Radiopharmaceutic Revenue & Forecasts
4.2.1 By Type - China Nuclear Medicine/Radiopharmaceutic Revenue, 2016-2021
4.2.2 By Type - China Nuclear Medicine/Radiopharmaceutic Revenue, 2022-2027
4.2.3 By Type - China Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2016-2027
4.3 By Type - China Nuclear Medicine/Radiopharmaceutic Sales & Forecasts
4.3.1 By Type - China Nuclear Medicine/Radiopharmaceutic Sales, 2016-2021
4.3.2 By Type - China Nuclear Medicine/Radiopharmaceutic Sales, 2022-2027
4.3.3 By Type - China Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2016-2027
4.4 By Type - China Nuclear Medicine/Radiopharmaceutic Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Nuclear Medicine/Radiopharmaceutic Market Size, 2021 & 2027
5.1.2 Diagnostic
5.1.3 Therapeutic
5.2 By Application - China Nuclear Medicine/Radiopharmaceutic Revenue & Forecasts
5.2.1 By Application - China Nuclear Medicine/Radiopharmaceutic Revenue, 2016-2021
5.2.2 By Application - China Nuclear Medicine/Radiopharmaceutic Revenue, 2022-2027
5.2.3 By Application - China Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2016-2027
5.3 By Application - China Nuclear Medicine/Radiopharmaceutic Sales & Forecasts
5.3.1 By Application - China Nuclear Medicine/Radiopharmaceutic Sales, 2016-2021
5.3.2 By Application - China Nuclear Medicine/Radiopharmaceutic Sales, 2022-2027
5.3.3 By Application - China Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2016-2027
5.4 By Application - China Nuclear Medicine/Radiopharmaceutic Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Overview
6.1.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales and Revenue in China Market (2016-2021)
6.1.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Product Description
6.1.5 GE Healthcare Recent Developments
6.2 Bracco Imaging
6.2.1 Bracco Imaging Corporation Information
6.2.2 Bracco Imaging Overview
6.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales and Revenue in China Market (2016-2021)
6.2.4 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product Description
6.2.5 Bracco Imaging Recent Developments
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Overview
6.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales and Revenue in China Market (2016-2021)
6.3.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product Description
6.3.5 Mallinckrodt Recent Developments
6.4 Lantheus Medical Imaging
6.4.1 Lantheus Medical Imaging Corporation Information
6.4.2 Lantheus Medical Imaging Overview
6.4.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales and Revenue in China Market (2016-2021)
6.4.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product Description
6.4.5 Lantheus Medical Imaging Recent Developments
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Overview
6.5.3 Bayer Nuclear Medicine/Radiopharmaceutic Sales and Revenue in China Market (2016-2021)
6.5.4 Bayer Nuclear Medicine/Radiopharmaceutic Product Description
6.5.5 Bayer Recent Developments
6.6 Jubilant Pharma
6.6.1 Jubilant Pharma Corporation Information
6.6.2 Jubilant Pharma Overview
6.6.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales and Revenue in China Market (2016-2021)
6.6.4 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Product Description
6.6.5 Jubilant Pharma Recent Developments
6.7 Nordion
6.7.1 Nordion Corporation Information
6.7.2 Nordion Overview
6.7.3 Nordion Nuclear Medicine/Radiopharmaceutic Sales and Revenue in China Market (2016-2021)
6.7.4 Nordion Nuclear Medicine/Radiopharmaceutic Product Description
6.7.5 Nordion Recent Developments
6.8 Eli Lilly
6.8.1 Eli Lilly Corporation Information
6.8.2 Eli Lilly Overview
6.8.3 Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales and Revenue in China Market (2016-2021)
6.8.4 Eli Lilly Nuclear Medicine/Radiopharmaceutic Product Description
6.8.5 Eli Lilly Recent Developments
6.9 SIEMENS
6.9.1 SIEMENS Corporation Information
6.9.2 SIEMENS Overview
6.9.3 SIEMENS Nuclear Medicine/Radiopharmaceutic Sales and Revenue in China Market (2016-2021)
6.9.4 SIEMENS Nuclear Medicine/Radiopharmaceutic Product Description
6.9.5 SIEMENS Recent Developments
6.10 China Isotope & Radiation
6.10.1 China Isotope & Radiation Corporation Information
6.10.2 China Isotope & Radiation Overview
6.10.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales and Revenue in China Market (2016-2021)
6.10.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product Description
6.10.5 China Isotope & Radiation Recent Developments
6.11 Yantai Dongcheng Biochemicals
6.11.1 Yantai Dongcheng Biochemicals Corporation Information
6.11.2 Yantai Dongcheng Biochemicals Overview
6.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales and Revenue in China Market (2016-2021)
6.11.4 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Product Description
6.11.5 Yantai Dongcheng Biochemicals Recent Developments
7 China Nuclear Medicine/Radiopharmaceutic Production Capacity, Analysis
7.1 China Nuclear Medicine/Radiopharmaceutic Production Capacity, 2016-2027
7.2 Nuclear Medicine/Radiopharmaceutic Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Nuclear Medicine/Radiopharmaceutic Supply Chain Analysis
9.1 Nuclear Medicine/Radiopharmaceutic Industry Value Chain
9.2 Nuclear Medicine/Radiopharmaceutic Upstream Market
9.3 Nuclear Medicine/Radiopharmaceutic Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Nuclear Medicine/Radiopharmaceutic Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Nuclear Medicine/Radiopharmaceutic in China Market
Table 2. Top Nuclear Medicine/Radiopharmaceutic Players in China Market, Ranking by Revenue (2019)
Table 3. China Nuclear Medicine/Radiopharmaceutic Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Nuclear Medicine/Radiopharmaceutic Revenue Share by Companies, 2016-2021
Table 5. China Nuclear Medicine/Radiopharmaceutic Sales by Companies, (Kiloton), 2016-2021
Table 6. China Nuclear Medicine/Radiopharmaceutic Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Nuclear Medicine/Radiopharmaceutic Price (2016-2021) & (US$/Ton)
Table 8. Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
Table 9. List of Tier 1 Nuclear Medicine/Radiopharmaceutic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Nuclear Medicine/Radiopharmaceutic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Tc-99
Table 12. Major Manufacturers of I-123/131
Table 13. By Type - China Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2016-2021
Table 17. By Type - China Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2022-2027
Table 18. By Application - China Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2016-2021
Table 22. By Application - China Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2022-2027
Table 23. GE Healthcare Corporation Information
Table 24. GE Healthcare Description and Major Businesses
Table 25. GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 26. GE Healthcare Nuclear Medicine/Radiopharmaceutic Product
Table 27. GE Healthcare Recent Developments
Table 28. Bracco Imaging Corporation Information
Table 29. Bracco Imaging Description and Major Businesses
Table 30. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 31. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product
Table 32. Bracco Imaging Recent Developments
Table 33. Mallinckrodt Corporation Information
Table 34. Mallinckrodt Description and Major Businesses
Table 35. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 36. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product
Table 37. Mallinckrodt Recent Developments
Table 38. Lantheus Medical Imaging Corporation Information
Table 39. Lantheus Medical Imaging Description and Major Businesses
Table 40. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 41. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product
Table 42. Lantheus Medical Imaging Recent Developments
Table 43. Bayer Corporation Information
Table 44. Bayer Description and Major Businesses
Table 45. Bayer Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 46. Bayer Nuclear Medicine/Radiopharmaceutic Product
Table 47. Bayer Recent Developments
Table 48. Jubilant Pharma Corporation Information
Table 49. Jubilant Pharma Description and Major Businesses
Table 50. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 51. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Product
Table 52. Jubilant Pharma Recent Developments
Table 53. Nordion Corporation Information
Table 54. Nordion Description and Major Businesses
Table 55. Nordion Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 56. Nordion Nuclear Medicine/Radiopharmaceutic Product
Table 57. Nordion Recent Developments
Table 58. Eli Lilly Corporation Information
Table 59. Eli Lilly Description and Major Businesses
Table 60. Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 61. Eli Lilly Nuclear Medicine/Radiopharmaceutic Product
Table 62. Eli Lilly Recent Developments
Table 63. SIEMENS Corporation Information
Table 64. SIEMENS Description and Major Businesses
Table 65. SIEMENS Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 66. SIEMENS Nuclear Medicine/Radiopharmaceutic Product
Table 67. SIEMENS Recent Developments
Table 68. China Isotope & Radiation Corporation Information
Table 69. China Isotope & Radiation Description and Major Businesses
Table 70. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 71. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product
Table 72. China Isotope & Radiation Recent Developments
Table 73. Yantai Dongcheng Biochemicals Corporation Information
Table 74. Yantai Dongcheng Biochemicals Description and Major Businesses
Table 75. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Gross Margin (US$/Ton) (2016-2021)
Table 76. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Product
Table 77. Yantai Dongcheng Biochemicals Recent Developments
Table 78. Nuclear Medicine/Radiopharmaceutic Production Capacity (Kiloton) of Key Manufacturers in China Market, 2019-2021 (Kiloton)
Table 79. China Nuclear Medicine/Radiopharmaceutic Capacity Market Share of Key Manufacturers, 2019-2021
Table 80. Nuclear Medicine/Radiopharmaceutic Market Opportunities & Trends in China Market
Table 81. Nuclear Medicine/Radiopharmaceutic Market Drivers in China Market
Table 82. Nuclear Medicine/Radiopharmaceutic Market Restraints in China Market
Table 83. Nuclear Medicine/Radiopharmaceutic Raw Materials
Table 84. Nuclear Medicine/Radiopharmaceutic Raw Materials Suppliers in China Market
Table 85. Typical Nuclear Medicine/Radiopharmaceutic Downstream
Table 86. Nuclear Medicine/Radiopharmaceutic Downstream Clients in China Market
Table 87. Nuclear Medicine/Radiopharmaceutic Distributors and Sales Agents in China Market
List of Figures
Figure 1. Nuclear Medicine/Radiopharmaceutic Product Picture
Figure 2. Nuclear Medicine/Radiopharmaceutic Segment by Type
Figure 3. Nuclear Medicine/Radiopharmaceutic Segment by Application
Figure 4. China Nuclear Medicine/Radiopharmaceutic Market Overview: 2020
Figure 5. China Nuclear Medicine/Radiopharmaceutic Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Nuclear Medicine/Radiopharmaceutic Revenue, 2016-2027 (US$, Mn)
Figure 7. Nuclear Medicine/Radiopharmaceutic Sales in China Market: 2016-2027 (Kiloton)
Figure 8. The Top 3 and 5 Players Market Share by Nuclear Medicine/Radiopharmaceutic Revenue in 2020
Figure 9. Tc-99 Product Picture
Figure 10. I-123/131 Product Picture
Figure 11. In-111 Product Picture
Figure 12. Xe-133 Product Picture
Figure 13. Th-201 Product Picture
Figure 14. By Type - China Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2016-2027
Figure 15. By Type - China Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2016-2027
Figure 16. By Type - China Nuclear Medicine/Radiopharmaceutic Price (US$/Ton), 2016-2027
Figure 17. Diagnostic
Figure 18. Therapeutic
Figure 19. By Application - China Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2016-2027
Figure 20. By Application - China Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2016-2027
Figure 21. By Application - China Nuclear Medicine/Radiopharmaceutic Price (US$/Ton), 2016-2027
Figure 22. GE Healthcare Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Bayer Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Nordion Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Eli Lilly Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. SIEMENS Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. China Nuclear Medicine/Radiopharmaceutic Production Capacity (Kiloton), 2016-2027
Figure 34. Nuclear Medicine/Radiopharmaceutic Industry Value Chain
Figure 35. Marketing Channels
  • 2021-2030 Report on Global Home Health Testing Services Market by Player, Region, Type, Application and Sales Channel
    Published: 30-Nov-2021        Price: US 2500 Onwards        Pages: 136
    This report studies the Home Health Testing Services market, covering market size for segment by type (Men's Health, Women's Health, etc.), by application (Individuals, Organizations & Enterprises, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Everlywell, Modern Fertility, Future Family, 23andMe, Cue Health, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analys......
  • 2021-2030 Report on Global Thioctic Acid (Alpha Lipoic Acid) Market by Player, Region, Type, Application and Sales Channel
    Published: 30-Nov-2021        Price: US 2500 Onwards        Pages: 102
    This report studies the Thioctic Acid (Alpha Lipoic Acid) market, covering market size for segment by type (Medical Grade, Food Grade, etc.), by application (Health Care, Pharmaceutical, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Tonghe, Shyndec, Fushilai Pharmaceutical, Maidesen, Taike Biological, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of g......
  • Global Pet Insect Repellent Market Growth 2021-2026
    Published: 26-Nov-2021        Price: US 3660 Onwards        Pages: 105
    According to this latest study, the 2021 growth of Pet Insect Repellent will have significant change from previous year. By the most conservative estimates of global Pet Insect Repellent market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Pet Insect Repellent market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026. This report present......
  • Global Calcium Supplements for Kids Market Growth 2021-2026
    Published: 26-Nov-2021        Price: US 3660 Onwards        Pages: 119
    According to this latest study, the 2021 growth of Calcium Supplements for Kids will have significant change from previous year. By the most conservative estimates of global Calcium Supplements for Kids market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Calcium Supplements for Kids market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026. ......
  • Global Pets Parasite Prevention and Control Market Growth 2021-2026
    Published: 26-Nov-2021        Price: US 3660 Onwards        Pages: 90
    According to this latest study, the 2021 growth of Pets Parasite Prevention and Control will have significant change from previous year. By the most conservative estimates of global Pets Parasite Prevention and Control market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Pets Parasite Prevention and Control market will register a % CAGR in terms of revenue, the global market size will reach US$ mil......
  • Global Animals Parasite Prevention and Control Market Growth 2021-2026
    Published: 26-Nov-2021        Price: US 3660 Onwards        Pages: 93
    According to this latest study, the 2021 growth of Animals Parasite Prevention and Control will have significant change from previous year. By the most conservative estimates of global Animals Parasite Prevention and Control market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Animals Parasite Prevention and Control market will register a % CAGR in terms of revenue, the global market size will reach......
  • Global Antisense Oligonucleotide Therapies Market Growth (Status and Outlook) 2021-2026
    Published: 26-Nov-2021        Price: US 3660 Onwards        Pages: 81
    According to this latest study, the 2021 growth of Antisense Oligonucleotide Therapies will have significant change from previous year. By the most conservative estimates of global Antisense Oligonucleotide Therapies market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Antisense Oligonucleotide Therapies market will register a % CAGR in terms of revenue, the global market size will reach US$ millio......
  • Global Cattle Vaccine Market Growth (Status and Outlook) 2021-2026
    Published: 26-Nov-2021        Price: US 3660 Onwards        Pages: 87
    According to this latest study, the 2021 growth of Cattle Vaccine will have significant change from previous year. By the most conservative estimates of global Cattle Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ 1449.6 million in 2020. Over the next five years the Cattle Vaccine market will register a 6.5% CAGR in terms of revenue, the global market size will reach US$ 1861.6 million by 2026. This report presents a ......
  • Global Pets Anti-infective Drugs Market Growth 2021-2026
    Published: 26-Nov-2021        Price: US 3660 Onwards        Pages: 101
    According to this latest study, the 2021 growth of Pets Anti-infective Drugs will have significant change from previous year. By the most conservative estimates of global Pets Anti-infective Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Pets Anti-infective Drugs market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026. This......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs